Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

59 results about "Drugs types" patented technology

Drugs under international control include amphetamine-type stimulants, coca/cocaine, cannabis, hallucinogens, opiates and sedative hypnotics. Countries have decided to control these drugs because they pose a threat to health.

Prodrug composition

A prodrug composition is provided which includes a pharmaceutical species and an amino acid having a covalent bond to the pharmaceutical species. The pharmaceutical species is characterized by bioavailability of 30% or less and a molecular weight in the range of 100-1000 Daltons. The composition is characterized further in that the pharmaceutical species is not acyclovir, ganciclovir, BRL44385, or penciclovir. Also described is an inventive method of delivering a pharmaceutical species to an individual including the step of orally administering an inventive prodrug to an individual. In one embodiment the prodrug includes a pharmaceutical species characterized by bioavailability of 30% or less, wherein the pharmaceutical species has a molecular weight in the range of 100-1000 Daltons. The inventive prodrug is transported from the gastrointestinal lumen by a specific transporter and is enzymatically cleaved to yield the pharmaceutical species, such that the pharmaceutical species is delivered to the individual.
Owner:HILFINGER JOHN

Drug purchasing system combining online and offline functions

The invention belongs to the retail field combining online and offline functions and provides a drug purchasing system combining online and offline functions. The system comprises a platform server, a user terminal, a seller terminal, a delivery terminal, a payment terminal and a remote database and is characterized in that the platform server comprises a drug purchasing list acquisition module used for acquiring drug purchasing lists, a drug type judgment module used of judging the type of drug, a drug purchasing list issuing module used for sending the drug purchasing lists to sellers, a purchasing mode selection module used for acquiring purchasing modes of users, an optimal seller selection module used for selecting an optimal seller in different purchasing modes and a drug checking module used for checking drug information. According to the invention, correct sources of prescription drug lists of purchased drugs are ensured; the drugs are checked, so it is ensured that users can buy true drugs; through delivery of drones, the burning need for drugs of users in emergent conditions is met; and quick and timely services are provided for the users.
Owner:蔡勇

Preparation method of multistage drug release carrier compounded by gelatin microspheres and calcium phosphate cement

InactiveCN101564556ARealize multi-level releaseAchieve timingBone implantGelatin microspheresEmulsion
A preparation method of a multistage drug release carrier compounded by gelatin microspheres and calcium phosphate cement takes plant oil as continuous phase, disperses the aqueous solution of gelatin in the plant oil to form emulsion and obtains the gelatin microspheres of different grain diameters by controlling the temperature and stirring time of the plant oil; corresponding substances is weighed according to the mass rate (5-20): (95-80) of the gelatin microspheres to the calcium phosphate cement powder, compound powders are obtained after uniform mixing and formulates compound powder sizing agent is prepared by blending NaH2PO4 with the mass percent concentration being 0.8 percent with the compound powder under room temperature for 60-90s; and the blended sizing agent is filled into a mold to be solidified for 1-2h under the conditions of constant temperature of 37 DEG C and 100 percent humidity and finally the compound carrier is obtained. The gelatin microspheres and the bone cement are compounded to construct the drug release compound carrier and encapsulated drug types are designed according to the difference of degradation rates of the gelatin microspheres, so as to realize the timed and quantitative release of different drugs, and simultaneously, as a bone repair support, the drug release carrier can finally substitute a calcium phosphate cement carrier support.
Owner:TIANJIN UNIV

Drug preparation instruction system

When drugs are prepared according to drug preparation order sheets printed by drug preparation order printers, it is desired to freely set the relation with the printers by setting data without directly connected and fixed to a control program of a control unit of a drug preparation order system so as to cope with e.g. relocations of drug preparation tables. As the drug preparation instruction system, a control unit and a plurality of drug preparation order printers are provided. In the data storage portion of the control unit, data showing the relation between drugs and drug types are stored. By reading drug type codes from inputted drug data, and by reading printer numbers corresponding to the respective drug type codes from a printer setting portion in which are stored data showing the relation between drug type codes and printer numbers, drug data are printed individually by the printers of the set numbers.
Owner:YUYAMA MFG CO LTD

Synchronous detection method for plurality of types of drug residues in water body

The invention provides a method for synchronous detection of multiple residual drugs in a water environment, and belongs to the technical field of pollutant enrichment detection in a water environment. The residual drugs include antibiotics, anti-inflammatory analgesics and antihypertensive drugs, etc., and the synchronous detection method includes the following steps: (1) water sample pretreatment: filter to remove suspended matter, adjust the pH value of the water sample; (2) solidify Phase extraction: use HLB solid-phase extraction column to enrich the target drug; (3) blow nitrogen to nearly dry, dilute to 1mL and vortex for testing; (4) use LC-MS / MS for detection on the machine. The synchronous detection method of the present invention can simultaneously detect 32 pharmaceutical pollutants in the water body by one-time sample injection, and the method has the advantages of high accuracy and sensitivity and low detection limit; meanwhile, the method is environmentally friendly and easy to operate.
Owner:DALIAN UNIV OF TECH

Packeted drug inspection device and method

It is determined whether the type of drug inserted into a packaging machine is correct, on the basis of the dispensing information of the drug to be packaged and the drug type information of the drug to be inserted into the packaging machine. Number-by-appearance information indicating the number of drugs for each outward appearance which are packaged in each packet is acquired. The image of each drug corresponding to each dose is captured. The number of drugs for each outward appearance which are packaged in each packet is counted on the basis of the captured image of the drugs. It is determined whether the number of drugs for each outward appearance is correct, on the basis of the number-by-appearance information and the counting result of the number-by-appearance counting unit. It is determined whether the occurrence or non-occurrence of a mix-up of the drugs can be determined, on the basis of at least the dispensing information of the drugs to be packaged and the drug type information of the drugs inserted into the packaging machine. It is determined whether the drugs packaged in each packet are correct.
Owner:FUJIFILM CORP

Method of preparing dendritic drugs

Synthetic design of drug-incorporated novel dendrimer structures for quantitatively controlled drug delivery. The dendritic drugs have better control and thus a quantitative drug release can be obtained. There are no prior art dendritic drugs that control release both sequentially and quantitatively like the dendritic drugs disclosed herein. The dendritic drugs are formed by incorporating multiple same type drug units or more than two different drug types into a dendritic cascade structure to form a dendrimer drug.
Owner:CENTRAL MICHIGAN UNIVERSITY

Method for predicating embryotoxicity of non-steroidal anti-inflammatory drug type novel pollutants on early-phase life stage of zebra fish

ActiveCN105044317AAddressing non-reflective typical NSAID sewage biotoxicityBiological testingLife stageFish embryo
The invention discloses a method for predicating the embryotoxicity of non-steroidal anti-inflammatory drug type novel pollutants on an early-phase life stage of zebra fish. The method comprises the following steps: exposing zebra fish embryos in the non-steroidal anti-inflammatory drug type novel pollutants which have equal logarithm space concentrations; recording the death rate and the aberration rate of the zebra fish embryos 7 days after exposing; and calculating by using SPSS software to obtain corresponding LC50 and teratogenetic EC50, which are used for evaluating the toxicity of the non-steroidal anti-inflammatory drug type novel pollutants. With the adoption of the method, the toxicity feature and the toxicity level of the non-steroidal anti-inflammatory drug type novel pollutants are subjected to an analytical test and quantitative description; and meanwhile, the method also can be used as an index for monitoring and evaluating the wastewater biological toxicity of non-steroidal anti-inflammatory drugs, and reference is provided for risk predication and evaluation of the potential biological toxicity of the pollutants in a water body.
Owner:GUANGDONG INST OF MICROBIOLOGY GUANGDONG DETECTION CENT OF MICROBIOLOGY

Intelligent classified storage management system for drug types

The invention discloses an intelligent classified storage management system for medicines, comprising a storage space partitioning module, a medicines sales statistics module, a storage path module, amedicines storage module, a storage space detection module, a cloud server and a display terminal; the storage space partitioning module comprises a storage space partitioning module, a medicines sales statistics module, a storage path module, a medicines storage module, a storage space detection module, a cloud server and a display terminal. The storage space partition module is connected with the drug sales statistics module, and the cloud server is connected with the storage space partition module, the drug sales statistics module, the storage path module, the storage space detection module, the drug warehousing module and the display terminal. The invention can partition the storage space of each drug under each drug type, the rationality of storage space is improved, The invention can reasonably allocate the storage space between each storage sub-unit, meet the storage demand, and judge whether the transportation path of each drug stored in each storage sub-unit is correct, thusimproving the judgment of the correctness of the drug storage path, realizing the intelligent classification storage of drugs, improving the storage efficiency and accuracy, and facilitating the management of drugs.
Owner:SHENZHEN NANSHUO MINGTAI TECH CO LTD

Drug network pharmacology intelligent and quantitative analysis method and system based on network target

The invention provides a drug network pharmacology intelligent and quantitative analysis method and system based on a network target original theory, wherein the method and system are used for measuring the overall effect of intervening a disease biological network by drugs (including various drug types such as Chinese and western drugs). The method can integrate qualitative and / or quantitative biological information related to diseases and drugs, takes the disease biological network as a target and realizes effect measurement of drug intervention on the disease biological network from the system and overall perspective, and reveals the overall action mechanism of the drugs. The method provides a qualitative and quantitative selectable measurement mode, measures the drug intervention network effect by adopting biological function multi-scale qualitative analysis and / or time-space multi-dimensional quantitative analysis, and provides a new key technique for breaking through the limitation of a traditional experience-based or single-target-based drug research mode, understanding a drug network regulation mechanism, and quickly and intelligently discovering pharmacodynamic substances, action mechanisms, curative effect objective indexes and clinical indications and the like.
Owner:TSINGHUA UNIV

Systems and methods for prescription drug packaging

Systems and methods for prescription drug packaging are described. In some embodiments, a determination that a member of a pharmacy benefit plan has had a plurality of prescription drugs that have previously been filled is made. An adjudication request for a prescription drug prescribed for the member is received. The adjudication request is based on a fulfillment request to fill the prescription drug. A determination that a blister packaging criterion has been met may be made based on a drug type of the prescription drug and a determination that the member has had the plurality of prescription drugs that have previously been filled. A blister fill instruction is transmitted based on receipt of the adjudication request and a determination that the blister packaging criterion has been met, wherein the blister fill instruction reflects that a pharmacy is to fill the prescription drug utilizing blister packaging. Additional methods and systems are disclosed.
Owner:EXPRESS SCRIPTS STRATEGIC DEV INC

Six-item detection device for drugs and manufacturing method thereof

The invention discloses a six-item detection device for drugs capable of detecting drug types in samples such as saliva quickly and a manufacturing method thereof. The six-item detection device for the drugs comprises a detection card, a detection test strip and a sample adding funnel. The detection test strip comprises a substrate and a sample pad, a combination pad, a detection film and an absorption pad. The sample pad is located in a sample adding slot and is located below the sample adding funnel. Colored microsphere labeled specific monoclonal antibodies for six drugs are arranged on thecombination pad, the detection film is provided with at least six detection lines corresponding to the six drugs. The detection lines coat synthetic antigens of corresponding drugs and the detectionlines are exposed in an observation window. The six drugs are morphine, methamphetamine, ketamine, dimethyldioxyamphetamine, etrahydro-cannabivarinic acid and cocaine. The six-item detection device for drugs can detect six common drugs in saliva, so that the convenience of drug detection in saliva is improved greatly. Compared with a conventional detection device, the detection efficiency is improved greatly.
Owner:GUANGDONG SHUNDE IND DESIGN INST GUANGDONG SHUNDE INNOVATIVE DESIGN INST

Embedded type graded drug release three-dimensional rack and preparation method thereof

The invention relates to an embedded type graded drug release three-dimensional rack and a preparation method of the rack. A rack inner-layer shaped body with high porosity is wrapped by a rack outer-layer shaped body with low porosity to form an embedded bi-layer structural rack. The classes of drugs carried by the inner layer and the outer layer of the rack are different. The graded distribution of drug classes and the graded distribution of rack microstructures are realized in the same rack, thereby obtaining the embedded two-graded drug release artificial rack. The preparation process of the multi-graded drug release rack comprises the three steps, namely, (1) freeze-forming of the drug carrying rack inner-layer shaped body; (2) freeze-forming of the drug carrying rack outer-layer wrapping shaped body; and (3) drying the embedded rack in a low temperature and vacuum. In the embedded multi-layer rack prepared in the invention, the content of calcium phosphate and the drug classes in a composite slurry used in each layer of the rack are respectively different; the degradation rate of the rack is related to the solid content of solid phase; as the solid content of the slurry is different, the degradation rate of the prepared rack is different; and the release rate of the drug is influenced by the rack degradation.
Owner:SHANGHAI UNIV

Intelligent management cabinet for poisonous and anesthetic drugs

The invention discloses an intelligent management cabinet for poisonous and anesthetic drugs, which comprises a cabinet body, a control assembly and a plurality of drug storage cells, and is characterized in that each drug storage cell is controlled to be opened and locked through an electromagnetic lock; the control assembly comprises a touch screen computer and an identity recognizer, and the identity recognizer and the electromagnetic lock are both connected with the touch screen computer; the touch screen computer can achieve the following steps that when identity information input by an anesthesia nurse is detected, the identity information is verified, and the corresponding drug storage cells are opened after the identity information passes verification; after the drug is replaced, the taking permission of each drug storage cell input by the anesthesia nurse is obtained; when the identity information input by an anesthetist is detected, the identity information is verified, and the operation room number, the drug box and drug types and the base number corresponding to the authority of the anesthetist are displayed after the verification is passed; and after confirmation operation of the anesthetist is received, the corresponding drug storage cells are opened. The system achieves the intelligent management of toxic and numb drugs, and improves the work efficiency.
Owner:ZHUJIANG HOSPITAL SOUTHERN MEDICAL UNIV

Methods and apparatuses for prediction of mechanism of activity of compounds

A platform configured to predict type or family of an unknown drug candidate compound, the platform including: a living cell or a tissue; a detector that measures an indicator of a cellular response by the living cell or tissue upon exposure to the unknown drug candidate compound; a memory configured to store data related to the indicator of the cellular response detected by the detector from a library of drug types and / or families; and one or more processing unit(s) configured to: process the data related to the indicator of the cellular response of the living cell or tissue upon exposure to the unknown drug candidate compound, and compare cellular response data from the library of drug types and / or families, so that a drug type and / or a drug family and / or a mechanism of action of the unknown drug candidate compound can be predicted on the basis of a similarity between the detected cellular response data of the unknown drug candidate compound and the cellular response data of the library of drug types and / or families. Also disclosed are methods of screening an unknown drug, including: comparing the data measured from a test cell to corresponding cellular response data in a library of known drug types, and determining a relationship between the unknown drug and a known drug type or a known drug family to predict the type or family of the unknown drug.
Owner:RGT UNIV OF CALIFORNIA +1

Application of bone morphogenetic protein-4 in screening drugs for resisting cardiac hypertrophy, heart failure or cardiac fibrosis

The invention discloses an application of bone morphogenetic protein-4 in screening drugs for resisting cardiac hypertrophy, heart failure or cardiac fibrosis and belongs to the field of biomedicine. Screened drug types comprise: bone morphogenetic protein-4 formation inhibitor, bone morphogenetic protein-4 antagonistic, bone morphogenetic protein-4 receptor antagonists and bone morphogenetic protein-4 downstream signal antagonistic. The invention also relates to an application of the drugs in preparation of medicines for resisting cardiac hypertrophy, heart failure and arrhythmia. Researches have found that bone morphogenetic protein-4 can induce myocardial hypertrophy, apoptosis and cardiac fibroblast collagen secretion increase, lead to occurrence of cardiac hypertrophy, heart failure and arrhythmia. However, drugs for antagonism of bone morphogenetic protein-4 and its cell signaling pathway can be used to inhibit occurrence of cardiac hypertrophy, inhibit cardiac fibrosis and minimize occurrence of cardiac cell death and arrhythmia. The invention provides a theoretical basis for realizing high-flux medicine screening, and is of practical guiding significance.
Owner:HARBIN MEDICAL UNIVERSITY

Traditional Chinese medicine decoction piece formula single machine

The invention relates to the technical field of a traditional Chinese medicine decoction piece, and particularly relates to a traditional Chinese medicine decoction piece single machine. Discharge hoppers of the traditional Chinese medicine decoction piece single machine are arranged on a weighing sensor and a weighing rechecking sensor, thus drug of the discharge hoppers can be weighted twice, and the weighing accuracy is ensured; the opening angle of a blocking door in the device can be adjusted according to the drug type and weight; when more drugs are required, the opening angle of the block door is big; when the drug weight approaches to the setting weight, the opening angle of the block door is small, thus the drug can rapidly reach the setting weight. Use of the traditional Chinese medicine decoction piece single machine can effectively reduce the labor intensity when a worker takes drugs, and reduce the bias of artificially weighing drugs, thus the drug weighing is more exact and faster. Besides, the traditional Chinese medicine decoction piece single machine is reasonable in structure design, convenient to use and repair, and suitable for popularizing and use.
Owner:戴一民

Drug discharge device

The invention relates to the technical field of medical articles, in particular to a drug discharge device. The drug discharge device is capable of easily and conveniently confirming the drug type and quickly realizing drug taking. The drug discharge device comprises a cabinet body, a drug taking hole is formed in the cabinet body, the inside of the cabinet body is connected with a plurality of drug storage hoppers through chain wheel conveying devices, a cross bar is arranged at the drug taking hole, and the cross bar is provided with a plurality of indication lamps corresponding to the drug storage hoppers.
Owner:WUXI LIKE LIFE MEDICAL TECH

Systems and methods for hyperspectral imaging and artificial intelligence assisted automated recognition of drugs

This disclosure relates to a system and a method for automated recognition of drugs. This disclosure also relates to a system for automated recognition of drugs comprising a hyper-spectral imaging system. This disclosure also relates to a hyper-spectral imaging system configured to automatically recognize drugs by using a neural network. This disclosure relates to training the neural network to identify a drug type (e.g., the name of the drug) based on an image (e.g., normal visible image and / or hyperspectral image) of the drug.
Owner:ALFRED E MANN INST FOR BIOMEDICAL ENG AT THE UNIV OF SOUTHERN CALIFORNIA

Automatic drug selling system based on cloud service

The invention relates to an automatic drug selling system based on cloud service. The system comprises automatic drug selling machines, a cloud service platform and a mobile phone user side. The cloud service platform obtains position, drug stock and drug type information of each automatic drug selling machine; the cloud service platform transmits the position, drug stock and drug type information of each automatic drug selling machine to a mobile phone APP; and a user can search the information of each drug selling machine through the mobile phone APP, selects the closest drug selling machine, selects required type and quantity of drugs through the mobile phone APP and carries out on-line payment through the mobile phone APP. According to the automatic drug selling system based on cloud service, automatic drug selling system technology based on cloud service is applied to automatic drug selling equipment, thereby facilitating people's lives greatly, and making drug purchase more convenient and quicker.
Owner:唐山高达科技有限公司

Medicine dispensing method and device for medicine dispensing system

The invention provides a medicine dispensing method and device for a medicine dispensing system, and the method comprises the following steps: obtaining a first medicine type from a prescription, themedicine dispensing quantity corresponding to the first medicine type being greater than or equal to 1, and the prescription comprising a plurality of medicine types and the medicine dispensing quantity corresponding to each medicine type; based on the first medicine type, controlling a medicine dispensing system to send out the to-be-verified medicine from a medicine outlet, controlling a camerato shoot a medicine box image of the to-be-verified medicine, and obtaining a second medicine type corresponding to the to-be-verified medicine from the medicine box image; and when it is determined that the first drug type and the second drug type are the same, subtracting one from the dispensing quantity corresponding to the first drug type in the prescription. In the medicine dispensing method,the system checks each box of dispensed prescription medicines one by one, so that the error probability of medicine type identification can be greatly reduced.
Owner:SUZHOU IRON TECH

Drug-loaded guided tissue regeneration membrane and preparation method thereof

The invention provides a drug-loading type guided tissue regeneration membrane and preparation method thereof. Polycaprolactone and other biodegradable aliphatic polyesters are used as raw materials and added with an antibacterial drug, and the materials are prepared into a single-layer guided tissue regeneration membrane through an electrospinning method. Or, polycaprolactone and degradable aliphatic polyester material are used as a dense layer, degradable natural polymer material and bio active particles are used as a loose layer, and an antibacterial drug is added to the dense layer; and the layers are prepared into a double-layer guided tissue regeneration membrane with different pore structures and biological activity through a layer by layer electrostatic spinning method. The membrane material provided by the invention has excellent biocompatibility, mechanical properties and degradation property consistent with tissue repair process, can effectively prevent the growth of fibroblasts towards tissue defects, at the same time promote the regeneration repair of tissue, does not have to taken out through a secondary operation; and the membrane material can effectively inhibit bacteria infection and inflammation after the operation, can be widely used in medical fields, such as guided tissue regeneration, postoperative adhesion prevention and drug delivery membrane.
Owner:BEIJING UNIV OF CHEM TECH +1

Dynamic performance evaluation device for water purifying agent used for oily sewage

The invention discloses a dynamic performance evaluation device for a water purifying agent used for oily sewage. According to the flow direction of the oily sewage, the device sequentially includes an oily sewage flow rate regulating unit, a dosing control unit, a variable oil-water separation unit, a simulated sedimentation unit, and a sewage storage and discharge control unit. Under the condition that actual operating working conditions of the oily wastewater in different oil fields can be simulated, the device is a dynamic evaluation device by changing different water quality, different flow rates, different drug types, different dosing concentration, different dosing positions, different oil-water separation processes, different water discharge heights to perform comprehensive measurement on the performance of the water purifying agent used for the oily sewage.
Owner:CNOOC TIANJIN BRANCH +1

Drug supply guarantee and management platform based on 5G and blockchain

The embodiment of the invention provides a medicine supply guarantee and management platform and method based on 5G and a blockchain, and aims to improve the efficiency and reliability of medicine management. The platform comprises a blockchain network, an RFID reader deployed in a medicine warehouse, and a medicine supply server. The RFID reader is used for periodically receiving a signal sent by the RFID tag attached to each medicine, generating a medicine supply transaction according to the received signal, and submitting the transaction to the blockchain network; each node of the blockchain network determines the types of drugs needing to be supplemented and supplied according to the drug stock carried in the transaction and the lowest stock of each drug agreed in the target smart contract; and the specified node of the blockchain network pushes the determined drug type to the drug supply server, so that the drug supply server sends a drug supply message to a terminal of a corresponding drug supplier according to the execution result.
Owner:肖雁萍

Inventory cardinal number adjustment system and method for drug library

According to the drug inventory cardinal number adjusting system and the drug inventory cardinal number adjusting method, the types and the number of the drugs called into the target drug library are determined according to different target drug library types and different drug types (standing drugs, seasonal drugs and special drugs), dynamic adjustment of the drug library inventory is achieved, the hospital drug management efficiency is improved, timely supply of drugs is guaranteed, the drug turnover rate is increased, drug inventory backlog is reduced, and the hospital drug storage cost is reduced.
Owner:北京华兴长泰物联网技术研究院有限责任公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products